trending Market Intelligence /marketintelligence/en/news-insights/trending/DxhuFQsNbfhQ6j2zBCWr0A2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Health Insurance Innovations revises FY'18 guidance


Tracking Credit Risk of a Major U.S. Retailer

Corporate America Not Likely To Unwind COVID-19 Debt Buildup Despite Credit Hits


Q&A: Navigating Climate Risk as a Financial Risk

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Health Insurance Innovations revises FY'18 guidance

Health Insurance Innovations Inc. has revised its full-year 2018 guidance in light of a new accounting standard that goes into effect at year-end.

The company experienced what it said was a record open enrollment period in the fourth quarter, but market dynamics related to and a shift in product focus has resulted in the company expecting results to be on the lower end of its previously announced guidance.

Revenue for the year is projected to be $315 million to $330 million, adjusted EBITDA is expected to be $67 million to $72 million and adjusted EPS is estimated to be $2.95 to $3.15.

The S&P Global Market Intelligence consensus normalized EPS estimate for the full year is $2.52.